Evidence map›Paper›PMID 40911543›Full record

ArticlePloS one2025

Economic burden and cost-effectiveness of treatments for open tibia fractures in Malawi: Economic analysis of a multicentre prospective cohort study.

Alexander Thomas Schade, Linda Alinafe Sande, Ewan Tomeny, Maureen Sabawo, Nyamulani Nohakhelha, Kaweme Mwafulirwa, Leonard Banza Ngoie, Andrew John Metcalfe, David Griffith Lalloo, William James Harrison and 2 more

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alexander Thomas SchadeMalawi-Liverpool-Wellcome Trust, Blantyre, Malawi.ORCID https://orcid.org/0000-0001-5957-3071
Linda Alinafe SandeMalawi-Liverpool-Wellcome Trust, Blantyre, Malawi.
Ewan TomenyLiverpool School of Tropical Medicine, Liverpool, United Kingdom.
Maureen SabawoKamuzu University of Health Sciences, Blantyre, Malawi.
Nyamulani NohakhelhaQueen Elizabeth Central Hospital, Blantyre, Malawi.
Kaweme MwafulirwaQueen Elizabeth Central Hospital, Blantyre, Malawi.
Leonard Banza NgoieKamuzu Central Hospital, Lilongwe, Malawi.
Andrew John MetcalfeUniversity of Warwick Medical School, Coventry, United Kingdom.
David Griffith LallooLiverpool School of Tropical Medicine, Liverpool, United Kingdom.ORCID https://orcid.org/0000-0001-7680-2200
William James HarrisonCountess of Chester NHS Foundation Trust, Chester, United Kingdom.ORCID https://orcid.org/0000-0001-7229-0041
Jason J MadanUniversity of Warwick Medical School, Coventry, United Kingdom.ORCID https://orcid.org/0000-0003-4316-1480
Peter MacPhersonUniversity of Glasgow, Glasgow, United Kingdom.ORCID https://orcid.org/0000-0002-0329-9613

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundOpen tibia fractures result in substantial lifelong disability for patients, and are expensive to treat. As the injury typically affects young working men, the societal costs from open tibia fractures are likely to also be high in low income countries, but remain largely unknown. We therefore investigated the overall societal costs and cost-effectiveness of different orthopaedic treatments at one year following an open tibia fracture in Malawi.

methodsThis study was a cost-utility analysis nested in a prospective cohort study from the healthcare- and societal-payer perspectives with a one-year time horizon. We obtained quality-adjusted life years (QALYs) from the EuroQoL 5 Dimension 3 Level (EQ-5D-3L) and patient lost productivity estimates at 6 weeks, and 3, 6, and 12 months post-injury. QALYs were calculated from utility scores were modelled within a hierarchical Bayesian multivariate modelling framework that jointly estimated individual-level trajectories in EQ-5D-3L scores and costs over follow-up. Direct treatment costs were obtained from a micro-costing study, and staff interviews at tertiary and district hospitals. Cost-effectiveness was reported in terms of societal cost per quality-adjusted life year (QALY). All costs were reported in 2021 United States dollars (USD).

resultsBetween February 2021 and March 2022, 287 participants with open tibia fractures were included. There were substantial costs to participants one year following injury with 42% (n = 112) working with a median monthly household income of US$40 (IQR: US$7-90) compared to 89% (n = 255) working pre-injury, with a median monthly household income of US$60 (IQR: US$36-144). The posterior median of societal costs at one year varied between US$751 (80% credible intervals [CrIs]: US$-751-2,389) for treatment with plaster of Paris (POP) in a district hospital for a Gustilo III injury, to US$2,428 (80% CrIs: US$995-5027) for intramedullary nail in central hospital for a Gustilo III injury. The largest cost-effectiveness from a societal perspective was between an intramedullary nail and amputation for a Gustilo III injury with a posterior mean of US$2,290 (95%HDI: 36-4,547) per QALY.

conclusionThe main finding was that open tibia fractures result in significant costs to patients, the healthcare system and society in Malawi. Although the funding of orthopaedic treatment can be difficult in countries with very limited healthcare budgets, the costs to society of ignoring this issue are very high. A re-balancing of health budgets (including from government and donors) is needed to prioritise trauma care to reduce the growing societal economic burden from injury.

Indexed as

Cost-Benefit AnalysisCost of IllnessFractures, OpenTibial FracturesAdultFemaleHumansMalawiMaleMiddle AgedProspective StudiesQuality-Adjusted Life YearsQuality of LifeYoung Adult

Identifiers

PMID40911543
PMCPMC12413004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.